<p>Synergistic effect of a retinoid X receptor-selective ligand bexarotene and docetaxel in prostate cancer</p>

Danyang Shen(Sir Run Run Shaw Hospital), Li Q Xia(Zhejiang University)
OncoTargets and Therapy
September 1, 2019
Cited by 7


Related Papers